Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Regenxbio Inc (NASDAQ: RGNX) closed at $8.82 down -2.65% from its previous closing price of $9.06. In other words, the price has decreased by -$2.65 from its previous closing price. On the day, 0.66 million shares were traded. RGNX stock price reached its highest trading level at $9.14 during the session, while it also had its lowest trading level at $8.65.
Ratios:
For a deeper understanding of Regenxbio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.13 and its Current Ratio is at 3.13. In the meantime, Its Debt-to-Equity ratio is 1.27 whereas as Long-Term Debt/Eq ratio is at 1.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on February 11, 2025, Downgraded its rating to Neutral and sets its target price to $14 from $38 previously.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 12 ’25 when Mills Kenneth T. sold 20,602 shares for $7.91 per share. The transaction valued at 163,046 led to the insider holds 475,103 shares of the business.
KENNETH MILLS bought 20,602 shares of RGNX for $154,927 on May 12 ’25. On Dec 30 ’24, another insider, VITTAL VASISTA, who serves as the Officer of the company, bought 20,041 shares for $7.41 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGNX now has a Market Capitalization of 445535232 and an Enterprise Value of 393928384. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.86 while its Price-to-Book (P/B) ratio in mrq is 2.08. Its current Enterprise Value per Revenue stands at 2.529 whereas that against EBITDA is -2.648.
Stock Price History:
The Beta on a monthly basis for RGNX is 1.17, which has changed by -0.29326922 over the last 52 weeks, in comparison to a change of 0.15005577 over the same period for the S&P500. Over the past 52 weeks, RGNX has reached a high of $13.48, while it has fallen to a 52-week low of $5.03. The 50-Day Moving Average of the stock is 1.63%, while the 200-Day Moving Average is calculated to be 6.28%.
Shares Statistics:
For the past three months, RGNX has traded an average of 872.09K shares per day and 742840 over the past ten days. A total of 50.39M shares are outstanding, with a floating share count of 45.78M. Insiders hold about 9.37% of the company’s shares, while institutions hold 84.35% stake in the company. Shares short for RGNX as of 1753920000 were 5484776 with a Short Ratio of 6.29, compared to 1751241600 on 6131126. Therefore, it implies a Short% of Shares Outstanding of 5484776 and a Short% of Float of 13.19.
